Health Care/Hospital

TELUS Mental Health Index: 40 per cent of workers in New Zealand have high mental health risk as productivity losses mount

Workers diagnosed with anxiety lose more than 68 working days of productivity per year, underscoring the economic impact ofNew Zealand's declining mental health scores AUCKLAND, New Zealand, Nov. 22, 2024 /PRNewswire/ - Today, TELUS Health released itsTELUS Mental Health Index ("the Index") with...

2024-11-22 00:00 1085

The GenScript Biotech Global Forum Makes a Strong Debut in Europe, Highlighting Breakthroughs in Cell and Gene Therapy Development

LONDON, Nov. 21, 2024 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, successfully hosted the European debut of itsGenScript Biotech Global Forum in London, UK. Since its inaugural session at the J.P. Morgan Healthcare Conference inS...

2024-11-21 23:46 1284

GATORADE AND MANCHESTER CITY PLAYERS UNVEIL #THENOD AS AN UNSPOKEN SUPERPOWER IN FOOTBALL

* Gatorade now has an official presence on the sidelines for both the UEFA Champions League and EA SPORTS FC™25, blending the real and virtual worlds of football. * To celebrate its expanded partnership with two of the world's hottest football platforms, Gatorade is fuelling peak physical and...

2024-11-21 22:39 2369

I-Mab to Participate at the Piper Sandler Healthcare Conference

The 36th Annual Healthcare Conference will be held in New York, December 3-5, 2024 ROCKVILLE, Md., Nov. 21, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB, the "Company"), a U.S.-based global biotech company, exclusively focused on the development of highly differentiated immunotherapies for the treat...

2024-11-21 20:00 1187

SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024

Launch of new application enables global access to highly recognized solid tumor profiling assay BOSTON and ROLLE, Switzerland, Nov. 21, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology leader in data-driven medicine, announced the global launch of MSK-IM...

2024-11-21 18:30 1310

3Shape A/S and Medit Corp. Reach Settlement in Patent Infringement Lawsuit

COPENHAGEN, Denmark, Nov. 21, 2024 /PRNewswire/ -- 3Shape A/S, a global innovator in digital dentistry with its market-leading intraoral (IOS) scanners, and Medit Corp, a leading provider of dental 3D scanners, today announced they have settled U.S. patent infringement litigation. Both companies...

2024-11-21 18:18 1316

111, Inc. to Participate in Fireside Chat with Water Tower Research on December 6, 2024

SHANGHAI, Nov. 21, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will part...

2024-11-21 18:00 1188

BioWorld by Clarivate Highlights Gaps in Women's Health Research and Investment in New Special Series

New seven-part series explores disparities in care, funding and innovation impacting half the world's population LONDON, Nov. 21, 2024 /PRNewswire/ -- BioWorld™ published by Clarivate Plc  (NYSE:CLVT), a leading global provider of transformative intelligence, has launched its new special series,'...

2024-11-21 16:00 1271

InxMed FAK Inhibitor Ifebemtinib Received Breakthrough Therapy Designation by China National Medical Products Administration for First-Line Non-Small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation

NANJING, China, Nov. 21, 2024 /PRNewswire/ -- InxMed Co., Ltd, a clinical-stage biotechnology company developing innovative therapies against cancer treatment resistance and metastasis, announced that China National Medical Products Administration (NMPA) has granted Ifebemtinib (IN10018) Breakthr...

2024-11-21 15:09 1654

HKBN collaborates with Evercare to launch monthly subscription plan for home care services

HONG KONG, Nov. 21, 2024 /PRNewswire/ -- Hong Kong Broadband Network Limited ("HKBN") has partnered with Evercare, a leading local health technology platform, to launch home care services for household customers, further enhancing HKBN's Infinite-play strategy with innovative healthcare offerings...

2024-11-21 14:27 1345

APRIL Group Supports National Health Development in Riau Province, Indonesia

SINGAPORE, Nov. 21, 2024 /PRNewswire/ -- Leading pulp, paper and board producer APRIL Group has further strengthened its commitment to improving public health by donating essential medical equipment to a local health facility in Riau province inSumatra, Indonesia, close to where the company's man...

2024-11-21 13:36 1588

DP Technology and Lepu Biopharma Announce Milestone Collaboration: Leveraging Advanced Computational Methods to Accelerate ADC Drug Innovation

This partnership has effectively integrated DP's ADC Linker-Payload design platform with Lepu's ADC technology development platform, capitalizing on their respective strengths. The overall optimization of the ADC drug has been achieved in a relatively short time. BEIJING, Nov. 20, 2024 /PRNewswi...

2024-11-21 13:01 1283

FWD Group and BRI Life become INSEAD case study

SINGAPORE and HONG KONG, Nov. 21, 2024 /PRNewswire/ -- FWD Group Holdings Limited ("FWD Group" or "FWD") today announced at an on-campus event inSingapore that its strategic partnership with PT Asuransi BRI Life ("BRI Life") will become a case study at INSEAD, one of the world's leading graduate ...

2024-11-21 12:33 1736

United Imaging Installs Another Flagship uMR OMEGA®, in New Mexico

X-Ray Associates of New Mexico (XRANM), with their motto "We Don't Follow. We Lead.", took decisive action to have the 75 cm 3T MRI scanner installed and clinically operational within ten months of seeing images at RSNA 2023. HOUSTON, Nov. 20, 2024 /PRNewswire/ -- United Imaging, a global leader ...

2024-11-21 09:09 1089

/C O R R E C T I O N -- Sky Labs/

In the news release, Sky Labs' Blood Pressure Monitoring Device Recognized for High Accuracy by the International Society of Hypertension, issued24-Oct-2024 by Sky Labs over PR Newswire, we are advised by the company that there are updates to the content. The complete, corrected release follows: ...

2024-11-21 08:00 1183

Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias

– Kura to receive a $330 million upfront payment and up to $1.2 billion in total milestone payments, including$420 million in near-term milestone payments and opt-in right for solid tumors – – Companies to jointly develop and commercialize ziftomenib; 50/50 profit share in the U.S.; Kura to lead...

2024-11-21 06:00 1741

Complete Genomics announces mpox virus amplicon sequencing panel at AMP

VANCOUVER, BC, Nov. 20, 2024 /PRNewswire/ -- Complete Genomics, a San Jose, Calif.-based genomic sequencer manufacturer, today announced at the 2024 Association for Molecular Pathology (AMP) Annual Meeting & Expo the launch of its mpox (MPXV) virus amplicon sequencing panel, part of its sequencin...

2024-11-21 01:01 1103

GBI Biomanufacturing Expands Capabilities with Automated Aseptic Fill-Finish for Drug Products

PLANTATION, Fla., Nov. 21, 2024 /PRNewswire/ -- GBI Biomanufacturing (GBI), one of the world's longest serving contract development and manufacturing organizations (CDMO), is pleased to announce the expansion of its Drug Product (DP)services, to include automated sterile fill and finish capabilit...

2024-11-21 01:00 1234

NAYO Captivates Audiences at Analytica China 2024 with its Unique Exhibition Style

SHANGHAI, Nov. 20, 2024 /PRNewswire/ -- NAYO proudly participated in the 12th Analytica China & Labtech China Congress 2024, the international trade fair for laboratory technology, analysis and biotechnology inChina. Breaking away from traditional exhibition norms, NAYO demonstrated its cutting-e...

2024-11-20 22:30 1417

Laekna Announces a Clinical Collaboration with Lilly to Develop LAE102, a Novel Monoclonal Antibody Targeting Activin Receptor Type 2A for The Treatment of Obesity

The collaboration will accelerate the global development of LAE102, a novel Activin Receptor Type 2 A (ActRIIA) Antagonistic Monoclonal Antibody (mAb) for muscle-preservingweight loss in Obesity LOS ANGELES, Nov. 20, 2024 /PRNewswire/ -- Laekna, Inc. (2105.HK) ("Laekna"), a global biotech compan...

2024-11-20 22:00 1674
1 ... 27282930313233 ... 860

Week's Top Stories